These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12498651)

  • 1. Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway.
    Yang JS; Ramanathan MP; Muthumani K; Choo AY; Jin SH; Yu QC; Hwang DS; Choo DK; Lee MD; Dang K; Tang W; Kim JJ; Weiner DB
    Emerg Infect Dis; 2002 Dec; 8(12):1379-84. PubMed ID: 12498651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence.
    van Marle G; Antony J; Ostermann H; Dunham C; Hunt T; Halliday W; Maingat F; Urbanowski MD; Hobman T; Peeling J; Power C
    J Virol; 2007 Oct; 81(20):10933-49. PubMed ID: 17670819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis.
    Samuel MA; Morrey JD; Diamond MS
    J Virol; 2007 Mar; 81(6):2614-23. PubMed ID: 17192305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of apoptosis prevents West Nile virus induced cell death.
    Kleinschmidt MC; Michaelis M; Ogbomo H; Doerr HW; Cinatl J
    BMC Microbiol; 2007 May; 7():49. PubMed ID: 17535425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway.
    Ramanathan MP; Chambers JA; Pankhong P; Chattergoon M; Attatippaholkun W; Dang K; Shah N; Weiner DB
    Virology; 2006 Feb; 345(1):56-72. PubMed ID: 16243374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations.
    Schlick P; Kofler RM; Schittl B; Taucher C; Nagy E; Meinke A; Mandl CW
    Vaccine; 2010 Aug; 28(36):5903-9. PubMed ID: 20600500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death receptor-mediated apoptotic signaling is activated in the brain following infection with West Nile virus in the absence of a peripheral immune response.
    Clarke P; Leser JS; Quick ED; Dionne KR; Beckham JD; Tyler KL
    J Virol; 2014 Jan; 88(2):1080-9. PubMed ID: 24198425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of ubiquitinated proteins is related to West Nile virus-induced neuronal apoptosis.
    Kobayashi S; Orba Y; Yamaguchi H; Kimura T; Sawa H
    Neuropathology; 2012 Aug; 32(4):398-405. PubMed ID: 22129084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Israeli strain IS-98-ST1 of West Nile virus as viral model for West Nile encephalitis in the Old World.
    Lucas M; Frenkiel MP; Mashimo T; Guénet JL; Deubel V; Desprès P; Ceccaldi PE
    Virol J; 2004 Nov; 1():9. PubMed ID: 15550172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999).
    Yang JS; Kim JJ; Hwang D; Choo AY; Dang K; Maguire H; Kudchodkar S; Ramanathan MP; Weiner DB
    J Infect Dis; 2001 Oct; 184(7):809-16. PubMed ID: 11550123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenicity of West Nile virus: molecular markers].
    Anishchenko M; Shchelkanov MIu; Alekseev VV; Lipnitskiĭ AV; Antonov VA; Dzharkenov AF; Bushkieva BTs; L'vov DN; Deriabin PG; Kolobukhina LV; L'vov DK
    Vopr Virusol; 2010; 55(1):4-10. PubMed ID: 20364664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
    Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
    J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High clonality of virus-specific T lymphocytes defined by TCR usage in the brains of mice infected with West Nile virus.
    Kitaura K; Fujii Y; Hayasaka D; Matsutani T; Shirai K; Nagata N; Lim CK; Suzuki S; Takasaki T; Suzuki R; Kurane I
    J Immunol; 2011 Oct; 187(8):3919-30. PubMed ID: 21908734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the West Nile virus capsid protein and the host cell-encoded phosphatase inhibitor, I2PP2A.
    Hunt TA; Urbanowski MD; Kakani K; Law LM; Brinton MA; Hobman TC
    Cell Microbiol; 2007 Nov; 9(11):2756-66. PubMed ID: 17868381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. West Nile virus neuroinvasive disease.
    Davis LE; DeBiasi R; Goade DE; Haaland KY; Harrington JA; Harnar JB; Pergam SA; King MK; DeMasters BK; Tyler KL
    Ann Neurol; 2006 Sep; 60(3):286-300. PubMed ID: 16983682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. West Nile virus capsid protein inhibits autophagy by AMP-activated protein kinase degradation in neurological disease development.
    Kobayashi S; Yoshii K; Phongphaew W; Muto M; Hirano M; Orba Y; Sawa H; Kariwa H
    PLoS Pathog; 2020 Jan; 16(1):e1008238. PubMed ID: 31971978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
    Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
    J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of host genes leading to West Nile virus encephalitis in mice brain using RNA-seq analysis.
    Kumar M; Belcaid M; Nerurkar VR
    Sci Rep; 2016 May; 6():26350. PubMed ID: 27211830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
    Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.